EUVIMEDEUVIMED entdecken
Crossref

An Overview of the EORTC-CLTG 2022 Congress

Nicola Humphry

EMJ Oncology · 2022

DOI: 10.33590/emjoncol/10045588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMJ Oncology, 2022. Verfasst von Nicola Humphry. Die Arbeit nennt 70 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This year's European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Tumours Group (CLTG) Annual Meeting was held in Madrid, Spain.Presentations covered a broad range of topics in the field of cutaneous lymphomas, from molecular mechanisms, through diagnostics and prediction of prognosis, to skin-directed and targeted therapies, combination therapies, and patient-reported outcomes.There was an overall feeling at the EORTC-CLTG meeting that further research is needed to better define the molecular basis for the different forms of cutaneous T cell lymphoma (CTCL), which will facilitate the development of novel treatments and therapeutic drug combinations.However, it was clear that significant progress had been made in understanding the biology behind CTCL, and that a broad range of therapies are available that provide symptomatic control in many patients.

Zitieren

APA

Humphry, N. (2022). An Overview of the EORTC-CLTG 2022 Congress. EMJ Oncology. https://doi.org/10.33590/emjoncol/10045588

Vancouver

Humphry N. An Overview of the EORTC-CLTG 2022 Congress. EMJ Oncology. 2022. doi:10.33590/emjoncol/10045588

BibTeX
@article{Humphry2022,
  author = {Humphry, Nicola},
  title = {An Overview of the EORTC-CLTG 2022 Congress},
  journal = {EMJ Oncology},
  year = {2022},
  doi = {10.33590/emjoncol/10045588}
}
Kostenlos starten →